IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vertex pharmaceuticals inc

CUSIP: 883556112 | 1 institutional holders

Quarters

Q3 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

Livforsakringsbolaget Skandia, Omsesidigt26,740
0.7% of portfolio›$12.4M
StyleTurnoverLocationFiled
Livforsakringsbolaget Skandia, Omsesidigt
26,740$12.4M0.7%GrowthMediumStockholm, Sweden2024-10-10